We used stored plasma samples (stored at −80°C) from HEV-infected patients consecutively tested for HEV RNA between 2005 and 2016 in the laboratory of Virology at Toulouse University Hospital, National Reference Center for HEV, where French laboratories can send samples for diagnosis and genotyping. These patients were acutely (HEV replication persisting for less than 3 months) or chronically HEV-infected (HEV replication persisting for more than 3 months). We selected 114 samples containing high HEV virus loads (>100,000 copies/ml) for PacBio SMRT sequencing. The HEV RNA concentrations were determined using a validated real-time polymerase chain reaction (Abravanel et al., 2012 (link)). This non-interventional study was supported by Toulouse University Hospital Center. The samples used were part of a collection identified by the French authorities (AC-2015-2518).
The positive control for PacBio SMRT sequencing was the strain VHP6 (passage 6 of TLS-09/M48 virus from the feces of an HEV-infected patient) cultured on HepG2/C3A cells (Lhomme et al., 2014 (link)), with two different human genome insertions in the PPR: a fragment of the L-arginine/glycine amidinotransferase (GATM) gene and a fragment of phosphatidylethanolamine binding protein 1 (PEBP1), each variant representing 50% of the quasispecies. Both were characterized by shot-gun deep sequencing (454 GS Junior system). Briefly, six overlapping amplicons were generated. For the library preparation, amplicons were nebulized according to 454 shotgun protocol (Roche/454-Life sciences) and the purified fragmented DNA was further processed according to 454 GS Junior Library construction protocol (Roche/454-Life sciences). The sequencing run was carried out on a Genome Sequencer Junior according to manufacturer instructions (Roche-454 LifeSciences). Data analysis was done with GS de Novo Assembler and GS Reference Mapper software.
The positive control for PacBio SMRT sequencing was the strain VHP6 (passage 6 of TLS-09/M48 virus from the feces of an HEV-infected patient) cultured on HepG2/C3A cells (Lhomme et al., 2014 (link)), with two different human genome insertions in the PPR: a fragment of the L-arginine/glycine amidinotransferase (GATM) gene and a fragment of phosphatidylethanolamine binding protein 1 (PEBP1), each variant representing 50% of the quasispecies. Both were characterized by shot-gun deep sequencing (454 GS Junior system). Briefly, six overlapping amplicons were generated. For the library preparation, amplicons were nebulized according to 454 shotgun protocol (Roche/454-Life sciences) and the purified fragmented DNA was further processed according to 454 GS Junior Library construction protocol (Roche/454-Life sciences). The sequencing run was carried out on a Genome Sequencer Junior according to manufacturer instructions (Roche-454 LifeSciences). Data analysis was done with GS de Novo Assembler and GS Reference Mapper software.
Full text: Click here